7. Vision The sector will be made up of a diverse range of successful, integrated pharmaceutical businesses (from SME to large) representing the full spectrum of the supply chain. The sector will be a growth industry, recognised internationally, with expertise in implementing innovative solutions to the industry. A centre of excellence (full range of pharmaceutical businesses) which is forward looking and leading The leading sector in the region
8. Prioritised SWOT analysis Strengths: Newcastle (as a City) Adaptability (of companies and workforce) Public sector support Stable workforce Brands (strong and attractive) Voice on national bodies Weaknesses: No sector champion Marketing and communication People management Equipment Pipelines Specific skills e.g. technical and QP Up-skilling required Opportunities Increase knowledge exchange Build a community with global reach Build the profile of the sector Create a strong network of companies “ intellectual” supply chain development TSB (new funding opportunity) Threats Less NCEs Lack of grants RDA changes Emerging markets Growth in generics Changes in business models Inertia Age demographic Leadership Cuts in health budget Geography Equipment base Price controls Regulations
9.
10. Forcefield Analysis Factor What is it/who is involved? Profile/regional plan Building a strong and attractive sector profile for the region A community with global reach Building a strong network of integrated companies with a global reach Technology Strategy Board Examine as an opportunity for getting funding Leadership Develop leaders of today and future leaders Knowledge exchange Encouraging the exchange of information between academia and industry to foster innovation Marketing & communication Improve marketing and communication within large companies to their HQ Sector champion Identify and appoint a sector champion People management Formally develop people within companies Specific skills Technical, QP, and up-skilling